FDA Passes New Rule On Foreign Drug Trials
The U.S. Food and Drug Administration will adopt new rules for foreign clinical studies used in drug approval applications, including adherence to standards of good clinical practice and approval by an...To view the full article, register now.
Already a subscriber? Click here to view full article